Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
magazineRe-rated Judges Scientific still has plenty of scope to grow
JUDGES SCIENTIFIC (JDG:AIM) £38.30
Gain to date: 68%
Original entry point: Buy at £22.80, 11 April 2019
Half year results delivered everything investors could have desired, underlining once again how science kit maker Judges Scientific (JDG:AIM) is a high quality business.
New first-half records were set for revenue, adjusted pre-tax profit, earnings per share, cash generation and dividends, the latter up 25% to 15p per share that is still covered seven times by adjusted earnings. All of this growth was achieved without any help from acquisitions.
That the share price jumped 7% on the day (18 September) and has continued its steady rise stands testament to how increasing numbers of investors like the stock.
Stockbroker Shore Capital increased its earnings per share forecasts by 9.2% to 208p for 2019, and by 5.2% to 208.2p for 2020.
Our original article claimed the stock deserved a higher price-to-earnings earnings multiple than 14.8 times 2019 earnings. The shares have jumped 68% yet the rating still only stands at 18.4 which is not excessive given its qualities and achievements.
SHARES SAYS: A very good business that we continue to support. Keep buying the shares.
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.
